Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;42(4):240-2.
doi: 10.4103/0253-7613.68432.

Rifampicin-induced thrombocytopenia

Ajay Kumar Verma  1 , Arpita Singh, Amol Chandra, Santosh Kumar, Rajesh Kumar Gupta
Affiliations

Rifampicin-induced thrombocytopenia

Ajay Kumar Verma et al. Indian J Pharmacol. 2010 Aug.

Abstract

In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment, and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain anti-tubercular drugs when the incriminating drug is taken by a susceptible individual. We report a case of rifampicin-induced thrombocytopenia, which although rare, needs attention.

Keywords: Rifampicin; thrombocytopenia; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Purpura on the ateriolateral aspect of thigh
Figure 2
Figure 2
Purpura on the flexor surface of arm.
See this image and copyright information in PMC

References

    1. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug induced thrombocytopenia a systematic review of published case reports. Ann Intern Med. 1998;129:886–90. - PubMed
    1. Wazny LD, Ariano RE. Evaluation and management of drug induced thrombocytopenia in the acutely ill patients. Pharmacotherapy. 2000;20:292–307. - PubMed
    1. Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug induced thrombocytopenia: Clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol. 1997;52:183–9. - PubMed
    1. Bassi L, Perna G, Silvestri LG. Antibodies against rifampicin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis. 1976;114:1189–90. - PubMed
    1. Blajchman MA, Lowry RC, Petil JE, Stradling P. Rifampicin induced immune thrombocytopenia. Br Med J. 1970;3:24–6. - PMC - PubMed